Clinical predictors of COVID‐19 severity and bleeding in the ACTIV‐4B COVID‐19 outpatient thrombosis prevention trial is a research paper published in American Journal of Hematology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: 1OT2HL156812‐01
NHLBI NIH HHS
Grant: OT2 HL156812
National Institutes of Health
Grant: 3OT2HL156812-01SD
ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center
FWCI
0.29
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals